PATENT CLAIM ANALYSIS

Application Number: 15767361
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "017400"]

Abstract:
Methods for treating learning disabilities associated with fetal alcohol syndrome and other neurological disorders by administering SK channel blockers, antagonists, inhibitors or modifiers like tamapin.

Claim (Index 6):
The method of  claim 1 , comprising administering at least one SK1 (KCNN1), SK2 (KCNN2), SK3 (KCNN3), and/or SK4 (KCNN4) channel blocker, antagonist, inhibitor or modifier to the subject.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 91.0
- Lexical Diversity: 1.03704
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15543514', '15042976', '15124304', '15580419', '10807414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7222090886015248
- 35 USC 102 Novelty (BERT): 0.5007689830551303
- Combined Prediction Score: 0.7000650780468853
- Mean Citation Score: 161.699814
- Max Citation Score: 166.45508
- Similarity Product: 95.35984284907818

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test